About this journal

Pathogens and Global Health is a journal of infectious disease and public health that focuses on the translation of molecular, immunological, genomics and epidemiological knowledge into control measures for global health threats. The journal publishes original innovative research papers, assesses and contextualises new ideas, trends and research, and interviews policy makers and opinion leaders on health subjects of international relevance. It provides a forum for scientific, ethical and political discussion of new innovative solutions for controlling and eradicating infectious diseases, with particular emphasis on those diseases affecting the poorest regions of the world.

PGH does not encourage submissions of papers describing local epidemiological surveys that do not have general implications for Public Health or for understanding pathogenic mechanism.

PGH is currently particularly interested in original research and reviews that document the development of RNA vaccines, against SARS-CoV-2 and other infectious diseases, whether that is in relation to molecular science and delivery, clinical data and safety, or economics and scalability. For COVID-19 and beyond, we are also interested in the development of monoclonal antibody therapies, their mechanism and production, and their implementation and impact.

We are also currently interested in topics that come under these themes:

– Drug development
– Economic modelling/Cost-benefit analyses
– Emerging viral diseases
– Fungal infections
– New insecticides
– Tick-borne diseases
– Uses of public health data/precision medicine
– Vaccines/Potential vaccination candidates
– Vector control technology

PGH encourages submissions of the following article types:

Review articles:

Review Articles provide a comprehensive summary of research on a topic, and a perspective on the state of the field and where it is heading. PGH welcomes the submission of unsolicited reviews. However, to ensure that a review is within the scope and interest of the journal, the Editor recommends that you contact the editorial office at [email protected] to discuss the topic further.

Examples of recently published review articles:

• Epidemiology of free-living amoebae in the Philippines: a review and update
  
• Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations
  
• Drought-related cholera outbreaks in Africa and the implications for climate change: a narrative review
  

Original Articles:

The journal welcomes detailed and thoroughly described original research* and should include the following headings: Introduction, Materials and Methods, Results, Discussion. The research should be in an area within an infectious disease or public health scope, and should be in an area of scientific importance. Research findings should be novel and be contextualised for an interdisciplinary readership.

Examples of recently published original articles:

• High genetic complexity but low relatedness in Plasmodium falciparum infections from Western Savannah Highlands and coastal equatorial Lowlands of Cameroon
  
• Investigation of MBL2 and NOS3 functional gene variants in suspected COVID-19 PCR (–) patients
  
• New insights on the Taenia solium tapeworm using molecular tools: age-based human definitive host prevalence and deliberation on parasite life span
  

Commentaries:

The journal accepts commentaries, which are short articles on research, ideas, trends, innovations, and the implications of technological, political, policy and legal changes on topics of interest to infectious disease and public health communities. Commentaries should critically evaluate the topic from your perspective, giving it wider context. These papers should be between 500-1,000 words and up to 5 references.

Examples of recently published commentaries:

• Malaria and malnutrition together jeopardizes India’s tribal community and disease elimination
  
• Immunogenicity of the BNT162b2 COVID-19 vaccine as a third dose (booster) following two doses of different primary series regimens in Thailand
  
• A tentative assessment of the changes in transmissibility and fatality risk associated with Beta SARS-CoV-2 variants in South Africa: an ecological study
  

 Methods:

 A method article is a regular length peer-reviewed, research-focused article type that aims to answer a specific question. It also describes an advancement or development of current methodological approaches and research procedures (akin to a research article), following the standard layout for research articles. Find out more about Method articles here.

Data Notes:

 Data notes are a short peer-reviewed article type that concisely describe research data stored in a repository. They increase the discoverability and transparency of your research, helping to comply with funder mandates on data sharing and make data FAIR (findable, accessible, interoperable and reusable). Find out more about Data Note articles here.

* Please note that the journal does not accept short communications at the initial submission stage. Short communications are only published in PGH when reviewers suggest that a submitted original article be published but only if it is re-formatted as a short communication. We also recommend that clinical papers are put into the context of their epidemiological or public health value – without this the journal is likely to recommend that it is submitted to a regional journal.

Editor-in-Chief:

• Professor Andrea Crisanti (Imperial College, London, UK)

Editorial Board:

• Dr Hesham M Al-Mekhlafi (Universiti Malaya, Malayasia)
• Dr Tito Bacarese-Hamilton (Non-executive director, AgPlus Diagnostics, UK)
• Dr Federica Bernardini (Imperial College London, UK)
  
• Professor emeritus, Bernard Brabin (Liverpool School of Tropical Medicine, Liverpool, UK)
• Professor Ilaria Capua (Emerging Pathogens Institute, University of Florida)
• Prof Antonio Cassone (University of Perugia, Perugia, Italy)
• Prof Alessandra Carattoli (Research Director, Istituto Superiore di Sanità, Rome, Italy)
• Professor George K Christophides (Imperial College London, UK)
• Dr Thomas Czypionka (Institute for Advanced Studies Vienna, Austria)
• Professor Jeremy Day (Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam)
• Professor Chia-Kwung Fan (Department of Parasitology, Taipei Medical University, Taiwan)
• Professor Marcelo Ferreira (Sao Paulo University, Sao Paulo, Brazil)
• Dr LeAnne Fox (Centers for Disease Control, Atlanta, GA, USA)
• Professor Sir Charles Godfray (Director, Oxford Martin School, University of Oxford, UK)
• Professor Jules Hoffmann (Chair of Integrative Biology, University of Strasbourg Institute for Advanced Study, France)
• Professor Panagiotis Karanis (University of Nicosia Medical School, Cyprus)
  
• Professor Axel Kroeger (University of Freiburg, Germany)
• Dr Elena Levashina (Max Planck Institute for Infection Biology, Germany)
• Dr Raphael Nyaruaba (Wuhan Institute of Virology, CAS, China)
  
• Dr John Nyirenda (Helmholtz Centre for Infection Research, Germany, and the University of Livingstonia, Malawi)
  
• Dr Emily Pascoe (Institute for Advanced Studies Vienna, Austria)
  
• Professor Yong Poovorawan (Chulalongkorn University, Bangkok, Thailand)
• Dr Rino Rappuoli (Chief Scientist & Head of External Research and Development at GlaxoSmithKline Vaccines, Italy)
• Dr Francesco Vladimiro Segala (The University of Bari Aldo Moro, Italy)
  
• Professor Roberta Spaccapelo (University of Perugia, Italy)
• Professor Afzal A Siddiqui (Texas Tech University Health Sciences Center, USA)